Abstract:e22093 Background: The epithermal growth factor receptor(EGFR) signaling pathways has been implicated in self-renewal of breast cancer stem cells. It has been proved that the EGFR tyrosine kinase inhibitor-gefitinib significantly decreased the mammosphere- forming efficiency(MFE) in ductal carcinoma in situ (DCIS) derived cancer cells. We investigated the response of breast cancer stem cells in breast cancer cell line MCF-7 to EGFR MAbs C225(cetuximab). Methods: Cells were used for nonadherent (i.e.,mammosphere) culture and were divided into four groups according to the different culture medium whether or not including exogenous EGF and MAbs C225. MFE was calculated as the number of mammospheres (≥60um) and was expressed as a percentage. We Compared the percentage of CD44 + /CD24 - cells from the four groups, and measured the levels of the Wnt and Notch-3 gene expression of the four groups. Results: There was no significant difference of MFE between groups. In the presence of exogenous EGF, MAbs C225 significantly decreased the MFE and the percentage of CD44 + /CD24 - cells of mammospheres compared with exogenous EGF alone(0.7% versus 1.5%, P < 0.001 and 4% versus 11%P < 0.001;respectively). In the absence of exogenous EGF, MAbs C225 aslo statistically decreased the MFE and the percentage of CD44 + /CD24 - cells of mammospheres compared with that of lacking exogenous EGF and MAbs C225(0.53% versus 1.3%,P = 0.003 and 9% versus 3%, P < 0.01;respectively). And we observed that the Notch-3 gene expression was compensativly increased in the two groups of addition of MAb C225. No significant differences of Wnt gene expression were observed between groups. Conclusions: EGFR MAbs C225 could disrupt mammoshpere formation and decrease the percentage of CD44 + /CD24 - cells of mammoshpere cells. The expression of Notch-3 is increased with the EGFR antagonistics in breast cancer stem cells. No significant financial relationships to disclose.

Radiosensitization Effect of EGFR Inhibitor C225 on Prostate Cancer Cell

Radiosensitivity of Prostate Cancer Cells is Enhanced by EGFR Inhibitor C225

EGFR Inhibitor C225 Increases the Radiosensitivity of Human Lung Squamous Cancer Cells

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Inhibitory Effects of Epigallocatechin Gallate (EGCG) and Cd2+ on the Growth of Prostate Cancer PC-3 Cell

Enhancement of Cetuximab on Radiosensitivity of Colorectal Cancer Cells Exposed to 125I Seeds

Combined effects of C225 and 125-iodine seed radiation on colorectal cancer cells

Epidermal growth factor receptor blocker C225 increases chemosensitivity and radiosensitivity of Docetaxel resistant human lung adenocarcinoma cell line SPC-A-1/docetaxel

Cetuximab Affects the Capicity of DNA Repair in Colorectal Cancer Cells after 125Ⅰ Seeds Irradiation

Radiosensitization of Cetuximab on Human Tongue Cancer Cell Line Tca8113

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

Effect of Low Does Irradiation on Expression of DNA Repair Genes and Ced Cycle of A549 and 2BS Cells

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145

Enhancing Effect of Isoflavonoid Genistein on Radiosensitivity of DU145 Prostate Cancer Cells

EGFR antibody radiosensitivity enhancement on CL187 cancer cells after continous low dose rate irradiation

Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay

Inhibitory Effect of Combination of Cetuximab and Irradiation on Colorectal Carcinoma CL187 Cells

The role of EGFR MAbs C225 in breast cancer stem cells

A Experimental Study on Inhibiting Effect of Cetuximab on Angingenesis

Combination of Genistein with Ionizing Radiation on Androgen-Independent Prostate Cancer Cells.